XML 16 R4.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Revenues:        
Total revenues $ 25,472 $ 34,565 $ 77,686 $ 76,099
Costs and expenses:        
Cost of sales 3,050 6,462 10,936 13,099
Research and development expenses 0 1,316 0 3,983
Selling, general and administrative expenses 9,313 27,607 43,279 83,052
Amortization of intangible assets 7,175 5,587 20,939 18,237
Restructuring charges 0 268 1,089 6,787
Total costs and expenses 19,538 41,240 76,243 125,158
Income (loss) from operations 5,934 (6,675) 1,443 (49,059)
Other (expense) income :        
Interest expense (2,495) (3,050) (7,783) (13,328)
Other gain (loss), net 344 253 747 (3,571)
Total other (expense) income (2,151) (2,797) (7,036) 38,894
Net income (loss) before income taxes 3,783 (9,472) (5,593) (10,165)
Income tax (expense) benefit (46) (1,050) (294) 6,374
Net income (loss) 3,737 (10,522) (5,887) (3,791)
Comprehensive income (loss) $ 3,737 $ (10,522) $ (5,887) $ (3,791)
Basic net income (loss) per share (in dollars per share) $ 0.08 $ (0.35) $ (0.14) $ (0.15)
Diluted net income (loss) per share (in dollars per share) $ 0.08 $ (0.35) $ (0.14) $ (0.15)
Shares used in computing basic net income (loss) per share (in shares) 44,969 29,891 42,550 24,958
Shares used in computing diluted net income (loss) per share (in shares) 45,055 29,891 42,550 24,958
Convertible notes        
Other (expense) income :        
Loss on extinguishment of debt $ 0 $ 0 $ 0 $ (47,880)
Senior Notes        
Other (expense) income :        
Loss on extinguishment of debt 0 0 0 (8,233)
Product sales, net        
Revenues:        
Total revenues 25,997 33,664 77,271 61,974
Commercialization agreement, net        
Revenues:        
Total revenues 0 0 0 11,258
Royalties and milestones        
Revenues:        
Total revenues 416 299 1,391 1,158
Other revenue        
Revenues:        
Total revenues (941) 602 (976) 1,709
Gralise        
Other (expense) income :        
Loss (Gain) on sale of assets 0 0 0 126,655
NUCYNTA        
Other (expense) income :        
Loss (Gain) on sale of assets $ 0 $ 0 $ 0 $ (14,749)